Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scientific IndustriesSCND 37 Debt-to-Equity is 0.10 as of Mar. 2026, which is 11% above its 10-year median of 0.09. GuruFocus rates SCND with a GF Score™ of 37/100 and a GF Value™ of $0.74 (Fairly Valued). The stock has 4 warning signs investors should review. Among 2,215 Hardware companies, Scientific Industries ranks better than 72.19% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Scientific Industries's Debt-to-Equity or its related term are showing as below:
SCND'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.09 Max: 0.16
Current: 0.1
During the past 13 years, the highest Debt-to-Equity Ratio of Scientific Industries was 0.16. The lowest was 0.00. And the median was 0.09.
SCND's Debt-to-Equity is ranked better than 72.19% of 2215
companies
in the Hardware industry
Industry Median: 0.27
vs SCND: 0.10
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Scientific Industries Debt-to-Equity Related Terms
Scientific Industries Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Scientific Industries's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SCND vs LCTC, QURT, FCUV: Debt-to-Equity Comparison
For the Scientific & Technical Instruments subindustry, Scientific Industries's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scientific Industries Debt-to-Equity vs Hardware Industry
For the Hardware industry and Technology sector, Scientific Industries's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Scientific Industries's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientific Industries (SCND) has a Debt-to-Equity of 0.10 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Scientific Industries and its competitors. This is 11% above median its historical median of 0.09. According to the industry distribution chart, Scientific Industries ranks #616 out of 2215 companies in the Hardware industry, placing it in the top 27.8%.
Is Scientific Industries' Debt-to-Equity too high?
Scientific Industries' current Debt-to-Equity of 0.10 is 11% above median its 10-year median of 0.09. The Hardware industry median Debt-to-Equity is 0.27. Scientific Industries' value of 0.10 is 63% below this industry median. Based on the distribution chart, Scientific Industries ranks #616 out of 2215 companies in the Hardware industry, which is above the industry midpoint. Overall, Scientific Industries has a GF Score™ of 37/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scientific Industries' Debt-to-Equity compare to LCTC and QURT?
According to the Hardware industry distribution chart, Scientific Industries ranks #616 out of 2215 companies for Debt-to-Equity. This puts Scientific Industries in the upper half of its industry. The industry median Debt-to-Equity is 0.27. Scientific Industries' value of 0.10 is 63% below this benchmark. While the company's 10-year median is 0.09 vs. the industry median of 0.27, Scientific Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Hardware company?
The median Debt-to-Equity among Hardware companies is 0.27, based on 2,215 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scientific Industries's current Debt-to-Equity of 0.10 is 63% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Scientific Industries and its competitors. For the Hardware industry, the median Debt-to-Equity is 0.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scientific Industries's current Debt-to-Equity is 0.10, which is 11% above median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientific Industries stock overvalued right now?
Based on GuruFocus' analysis, Scientific Industries (SCND) is currently considered Fairly Valued. The stock's GF Value™ is $0.74, compared to a current price of $0.67 — trading 9% below its estimated fair value. The current Debt-to-Equity is 0.10, which is 11% above median its 10-year median of 0.09 and 63% below the Hardware industry median of 0.27. Scientific Industries' overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Scientific Industries (SCND), the current Debt-to-Equity is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scientific Industries (SCND) Overvalued in 2026?
Based on GuruFocus' analysis, Scientific Industries stock appears to be undervalued.
The current stock price of $0.67 is trading 9% below its estimated GF Value™ of $0.74.
GuruFocus considers Scientific Industries to be Fairly Valued.
Key valuation signals for SCND:
Debt-to-Equity: 0.10 (11% above median its 10-year median of 0.09)
GF Value™: $0.74 vs. price of $0.67 (9% below fair value)
Industry Position: 63% below the Hardware median (#616 of 2215)
No single metric tells the full story. See the SCND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scientific Industries Inc is engaged in the design, manufacture, and marketing of benchtop laboratory equipment. Its products are used for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, petrochemical companies, and other industries performing laboratory-scale research. The company's operating segment includes Benchtop Laboratory Equipment, Bioprocessing Systems and Corporate. It generates maximum revenue from the Benchtop Laboratory Equipment segment. The company offers equipment products such as mixers, shakers, stirrers, refrigerated incubators, pharmacy balances and scales, force gauges, catalyst instruments, reactor systems, and high throughput systems.
37GF Score
Get the complete analysis for SCND
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SCND has been successfully added to your 
